Mucinex Line Extensions Underscore Adams’ Commitment To Building OTCs
This article was originally published in The Tan Sheet
Executive Summary
A major task facing Adams Respiratory Therapeutics' new VP-OTC Marketing & Business Development Robert Casale will be to plan a Fall 2004 launch of extensions to the firm's Mucinex expectorant brand